Annual EBIT
-$247.01 M
-$59.95 M-32.05%
31 December 2023
Summary:
Lyell Immunopharma annual earnings before interest & taxes is currently -$247.01 million, with the most recent change of -$59.95 million (-32.05%) on 31 December 2023. During the last 3 years, it has fallen by -$35.07 million (-16.55%). LYEL annual EBIT is now -141.95% below its all-time high of -$100.83 million.LYEL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$50.51 M
+$1.02 M+1.99%
30 September 2024
Summary:
Lyell Immunopharma quarterly earnings before interest & taxes is currently -$50.51 million, with the most recent change of +$1.02 million (+1.99%) on 30 September 2024. Over the past year, it has increased by +$8.53 million (+14.45%). LYEL quarterly EBIT is now -241.62% below its all-time high of -$14.78 million, reached on 31 December 2022.LYEL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$217.12 M
+$8.53 M+3.78%
30 September 2024
Summary:
Lyell Immunopharma TTM earnings before interest & taxes is currently -$217.12 million, with the most recent change of +$8.53 million (+3.78%) on 30 September 2024. Over the past year, it has dropped by -$14.83 million (-7.33%). LYEL TTM EBIT is now -557.85% below its all-time high of -$33.00 million, reached on 31 March 2020.LYEL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYEL EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -32.0% | +14.4% | -7.3% |
| 3 y3 years | -16.6% | -2.7% | -5.0% |
| 5 y5 years | - | - | - |
LYEL EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -32.0% | at low | -241.6% | +26.4% | -19.9% | +12.1% |
| 5 y | 5 years | -141.9% | at low | -241.6% | +50.8% | -557.9% | +12.1% |
| alltime | all time | -141.9% | at low | -241.6% | +50.8% | -557.9% | +12.1% |
Lyell Immunopharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$50.51 M(-2.0%) | -$217.12 M(-3.8%) |
| June 2024 | - | -$51.53 M(-7.3%) | -$225.65 M(-6.0%) |
| Mar 2024 | - | -$55.58 M(-6.6%) | -$240.03 M(-2.8%) |
| Dec 2023 | -$247.01 M(+32.0%) | -$59.51 M(+0.8%) | -$247.01 M(+22.1%) |
| Sept 2023 | - | -$59.04 M(-10.4%) | -$202.28 M(-3.5%) |
| June 2023 | - | -$65.91 M(+5.4%) | -$209.68 M(+15.8%) |
| Mar 2023 | - | -$62.56 M(+323.1%) | -$181.04 M(-3.2%) |
| Dec 2022 | -$187.06 M | -$14.78 M(-77.7%) | -$187.06 M(-14.9%) |
| Sept 2022 | - | -$66.44 M(+78.3%) | -$219.81 M(+8.5%) |
| June 2022 | - | -$37.26 M(-45.7%) | -$202.54 M(-11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$68.58 M(+44.3%) | -$227.98 M(+6.1%) |
| Dec 2021 | -$214.78 M(+1.3%) | -$47.54 M(-3.3%) | -$214.78 M(+3.9%) |
| Sept 2021 | - | -$49.16 M(-21.6%) | -$206.76 M(+6.3%) |
| June 2021 | - | -$62.71 M(+13.3%) | -$194.44 M(-17.0%) |
| Mar 2021 | - | -$55.37 M(+40.1%) | -$234.30 M(+10.6%) |
| Dec 2020 | -$211.94 M(+107.6%) | - | - |
| Dec 2020 | - | -$39.52 M(+7.3%) | -$211.94 M(+22.9%) |
| Sept 2020 | - | -$36.84 M(-64.1%) | -$172.41 M(+27.2%) |
| June 2020 | - | -$102.57 M(+210.8%) | -$135.57 M(+310.8%) |
| Mar 2020 | - | -$33.00 M | -$33.00 M |
| Dec 2019 | -$102.09 M | - | - |
FAQ
- What is Lyell Immunopharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Lyell Immunopharma?
- What is Lyell Immunopharma annual EBIT year-on-year change?
- What is Lyell Immunopharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly EBIT year-on-year change?
- What is Lyell Immunopharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Lyell Immunopharma?
- What is Lyell Immunopharma TTM EBIT year-on-year change?
What is Lyell Immunopharma annual earnings before interest & taxes?
The current annual EBIT of LYEL is -$247.01 M
What is the all time high annual EBIT for Lyell Immunopharma?
Lyell Immunopharma all-time high annual earnings before interest & taxes is -$100.83 M
What is Lyell Immunopharma annual EBIT year-on-year change?
Over the past year, LYEL annual earnings before interest & taxes has changed by -$59.95 M (-32.05%)
What is Lyell Immunopharma quarterly earnings before interest & taxes?
The current quarterly EBIT of LYEL is -$50.51 M
What is the all time high quarterly EBIT for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly earnings before interest & taxes is -$14.78 M
What is Lyell Immunopharma quarterly EBIT year-on-year change?
Over the past year, LYEL quarterly earnings before interest & taxes has changed by +$8.53 M (+14.45%)
What is Lyell Immunopharma TTM earnings before interest & taxes?
The current TTM EBIT of LYEL is -$217.12 M
What is the all time high TTM EBIT for Lyell Immunopharma?
Lyell Immunopharma all-time high TTM earnings before interest & taxes is -$33.00 M
What is Lyell Immunopharma TTM EBIT year-on-year change?
Over the past year, LYEL TTM earnings before interest & taxes has changed by -$14.83 M (-7.33%)